Reason: Went private
Last recorded trade on: January 5, 2024
Source: https://njbiz.com/tabula-rasa-to-go-private-after-570m-acquisition/
P/E ratio for Tabula Rasa HealthCare (TRHC)
P/E ratio on January 5, 2024 (TTM): -2.73
According to Tabula Rasa HealthCare 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.72727. At the end of 2022 the company had a P/E ratio of -0.8128.
P/E ratio history for Tabula Rasa HealthCare from 2016 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.8128 | -81.58% |
| 2021 | -4.41 | -62% |
| 2020 | -11.6 | -62.32% |
| 2019 | -30.8 | 20.32% |
| 2018 | -25.6 | -167.55% |
| 2017 | 37.9 | -142.42% |
| 2016 | -89.4 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 | -46.2 | 1,593.31% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.